Tenderwize
Retour à la recherche

Pharmaceutical discount agreements open-house procedure

IKK classic·Dresden, Germany·Deadline Jan 05, 2028 · 495 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume commitment; actual revenue is uncertain and dependent on market conditions.

The agreement may be terminated if exclusive discount agreements for the same active ingredients come into effect durin...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 2 lots
  • Duration until Feb 2028
  • Non-exclusive discount agreements for pharmaceutical products (Dronabinol and medical cannabis extract) under §130a SGB V.
  • Open-house procedure allowing continuous enrollment from March 2026 to February 2028.
Afficher le résumé complet

The IKK classic health insurance fund announces non-exclusive discount agreements (Rabattverträge) for pharmaceutical products under §130a SGB V via an open-house procedure for two lots: Dronabinol and medical cannabis extract. The procedure allows continuous enrollment from March 2026 to February 2028. No estimated values are provided. Submission is via email or postal mail; electronic submission is not supported. Eligibility is restricted to pharmaceutical entrepreneurs per §4 Abs. 18 AMG.

Risques

No estimated value or volume commitment; actual revenue is uncertain and dependent on market conditions.

The agreement may be terminated if exclusive discount agreements for the same active ingredients come into effect durin...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur per §4 Abs. 18 AMG.

Administrative

  • Submit signed contract, all necessary evidence, self-declarations, and trade register extract (not older than 6 months at contract start).
  • Submission via email to [email protected] or by postal mail; electronic submission not allowed.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Lot 2

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Acheteur

Localisation

Dresden, DEU

Identifiant

993-80175-34

Activité

Health

Lots (2)

LOT-0001

Dronabinol (Active Ingredient)

Non-exclusive discount agreement for the active ingredient Dronabinol, all dosage forms and package sizes. Contract duration from March 2026 to February 2028, with possible extension by up to 12 months at IKK classic's discretion.

SuppliesEU fundedElectronic submission

Localisation

DED21, Germany

Durée

Feb 2026 - Feb 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Date limite

Deadline Jan 05, 2028

LOT-0002

Medical Cannabis Extract

Non-exclusive discount agreement for medical cannabis extract in various forms (LOE/EXTR/OEL/SUB), all THC/CBD strengths and package sizes. Contract duration from March 2026 to February 2028, with possible extension by up to 12 months.

SuppliesEU fundedElectronic submission

Localisation

DED21, Germany

Durée

Feb 2026 - Feb 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; participation is based on fulfilling non-negotiable terms.

Date limite

Deadline Jan 05, 2028

Détails de la procédure

Date de publication
18 Jan 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
36907-2026

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30